NTII Neurobiological Technologies (MM)

Neurobiological Technologies, Inc. To Report Fiscal 2004 Third Quarter Financial Results and Host Conference Call on May 10, 2004 RICHMOND, Calif., May 3 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) announced today it will release its fiscal 2004 third quarter financial results on May 10, 2004. Paul E. Freiman, President and Chief Executive Officer, will host an investor conference call that same day to review the company's financial results and operations. The details for the call are as follows: Live Call: * Date: Monday, May 10, 2004 * Time: 10:30 a.m. EDT, 7:30 a.m. PDT * Dial-in number: 800-289-0468 Web Cast of Call: * A live web cast can be accessed by going to: http://www.shareholder.com/ntii/medialist.cfm * The call will be archived and accessible at the same website for one year Telephonic Replay: * A playback of the conference call will be available from 1:30 p.m. EDT through midnight, Wednesday, May 19 EDT * Replay number: 888-203-1112 (U.S. and Canada) & 719-457-0820 (International) * Replay access code: 734934 Neurobiological Technologies, Inc. NTI is an emerging drug development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. The Company's strategy is to in-license and develop early- and later-stage drug candidates that target major medical needs and which can be rapidly commercialized. The Company's experienced management team oversees the human clinical trials necessary to establish preliminary evidence of efficacy and seeks partnerships with pharmaceutical and biotechnology companies to complete development and marketing of its product candidates. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Paul E. Freiman, President & CEO of Neurobiological Technologies, Inc., +1-510-262-1730; or Roger Pondel or Rob Whetstone, both of PondelWilkinson Inc, +1-323-866-6050 Web site: http://www.ntii.com/

Copyright